Is Lexicon Pharmaceuticals, Inc. overvalued?

Lexicon Pharmaceuticals, Inc. (LXRX) — key valuation metrics and fundamentals.

No verdict

Price

$1.90

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$844.0M

Dividend yield

0.0%

Return on equity

-40.4%

Sector

Healthcare

Fair value compares LXRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks